"10.1371_journal.pone.0146687","plos one","2016-01-12T00:00:00Z","Elizabeth P St. John; Birgitte B Simen; Gregory S Turenchalk; Michael S Braverman; Isabella Abbate; Jeroen Aerssens; Olivier Bouchez; Christian Gabriel; Jacques Izopet; Karolin Meixenberger; Francesca Di Giallonardo; Ralph Schlapbach; Roger Paredes; James Sakwa; Gudrun G Schmitz-Agheguian; Alexander Thielen; Martin Victor; Karin J Metzner; Martin P Däumer; 454 HIV-1 Alpha Study Group","454 Life Sciences, A Roche Company, Branford, CT, United States of America; National Institute for Infectious Diseases L. Spallanzani, Rome, Italy; Janssen Infectious Diseases—Diagnostics bvba, Beerse, Belgium; Plateforme Génomique Toulouse/Laboratoire Génétique Cellulaire, Toulouse, France; Blutzentrale Linz, Linz, Austria; INSERM U563, Toulouse, France; Robert Koch-Institute, Berlin, Germany; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Functional Genomics Center Zurich, University of Zurich, ETH Zurich, Zurich, Switzerland; Institut de Recerca de la SIDA–IrsiCaixa, Badalona, Spain; Technology Innovation Agency-National Genomics Platform, Durban, South Africa; Roche Applied Science, Penzberg, Germany; Institute of Immunology and Genetics, Kaiserslautern, Germany; Institute of Medical Virology, University of Zurich, Zurich, Switzerland","Conceived and designed the experiments: EPSJ BBS GST MSB GGS MV MPD. Performed the experiments: IA JA OB CG JI KM FdG RS RP JS AT KJM MPD. Analyzed the data: EPSJ BBS GST MSB IA JA OB CG JI KM FdG RS RP JS GGS AT MV KJM MPD. Contributed reagents/materials/analysis tools: EPSJ BBS GST MSB GGS MV MPD. Wrote the paper: EPSJ BBS KJM MPD.","At the time of the study, EPSJ, BBS, MSB, GST, GGSA, and MV were employees of 454 Life Sciences, a Roche Company and Roche Applied Science. MSB owns Roche stocks. KJM has received travel grants and honoraria from Gilead Sciences, Roche Diagnostics, Tibotec, Bristol-Myers Squibb, and Abbott; the University of Zurich has received research grants from Gilead, Roche, and Merck Sharp & Dohme for studies that KJM serves as principal investigator, and advisory board honoraria from Gilead Sciences. MPD has received travel grants from Abbott and MSD Sharp & Dohme, has received a research grant from MSD Sharp & Dohme (IISP ID#: 34988), and has been an adviser for Merck Sharp & Dohme, Gilead Sciences, and Janssen & Cila. JA is employed by Janssen Infectious Diseases – Diagnostics bvba, a Johnson & Johnson company, and owns stocks of this company. All other authors declare no competing interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Elizabeth P St. John","EPSJ",20,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
